A Q&A guide to life sciences regulation in Finland.
This Q&A provides a high-level overview of key practical issues, including life sciences clinical trials, manufacturing, marketing, abridged procedure, pharmacovigilance, data privacy, packaging and labelling, biological medicines, medical devices, health care IT, combination products, borderlines, and natural health products.
Read the Finland chapter we contributed: Life Sciences Regulation in Finland: Overview
Read also: Life Sciences Commercialisation in Finland: Overview